ARCHIVES

Leukemia Society, NCI, Discuss Funding, Congressional Language On Centers In

This article is from The Cancer Letter archive.

Vol. 20 No. 02 | January 14, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

Crout, Finkel Replaced at FDA; Hayes Combine Biologics, Drugs

April 2, 1982

NCI’s International Program Growing, With More Agreements, $8 Million In Contracts And Grants

August 8, 1975

NCI Supercomputer To Be Available To Extramural Scientists

June 8, 1984

First analysis From Profiles Reveal New Data On Centers

November 18, 1977

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006